Retatrutide ZPHC — 15 mg (15 mg * 1 vial)

Retatrutide — triple agonist (GLP-1 / GIP / GCGR)
1 lyophilised vial × 15 mg + 1 vial bacteriostatic water (10 ml)

• Triple-pathway metabolic boost: GLP-1, GIP & glucagon-receptor activation work synergistically to suppress appetite, elevate energy expenditure and promote rapid fat-loss.
• Once-weekly research dosing: extended half-life supports a single sub-Q injection per week.
• Reconstitution: add 2 ml bacteriostatic water (provided) → 7.5 mg/ml; swirl gently, avoid foaming. Store at 2–8 °C.
• Titration guide (research): Week 1–4 → 0.25 mg • Week 5–8 → 0.5 mg • escalate up to 1.5–2 mg weekly if well-tolerated. Increase gradually to minimise GI effects.
• Pharma-grade QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; each vial includes a scratch-code for authenticity verification.
• Includes 10 ml bacteriostatic water • cold-chain packed • tamper-evident vial • discreet, tracked worldwide delivery.